Frederico Giunchetti graduated in Electrical Engineering, post-graduated and Master of Science in Automation and Industrial Electrical Systems. He started his career in Unilever, holding various roles in the areas of Projects, Maintenance, TPM and Manufacturing for 10 years. After moving to Novartis / Sandoz, he has been taking on responsibilities in a number of different Engineering positions in Latin America and Europe for the last 18 years. Currently, he’s appointed as Head Maintenance & Asset Reliability in Sandoz, responsible for Assets Maintenance in 18 sites in the network and the overall business process ownership for Maintenance and Calibration.

The Pop in my job: I`m fascinated by continuous improvement and I see Maintenance as a PDCA cycle, as a continuous process to be improved every single day, not at all as a routine job. My motivation comes from making people also understand this mindset, and truly live as they want to make it better in every moment, so that we as individuals and our Company can be better today than we were yesterday. And in Sandoz, I have the opportunity to pursue this vision.

I am a passionate Maintenance, Reliability, and Turnaround (MRTA) Expert with extensive experience in maintenance execution, operational excellence, and continuous improvement in some of the world’s largest oil and gas integrated projects and petrochemical facilities (Shell, LyondellBasell, and Takeda).

My expertise spans maintenance planning and execution, CMMS (Computerized Maintenance Management Systems), equipment criticality analysis, FMEA, and the development and implementation of asset tactics in SAP. I have hands-on experience in supervising multidisciplinary teams, risk and reliability management (RRM), and integrity assurance through systems like CIMS (Corrosion and Inspection Management).

Notable achievements include receiving Shell’s Upstream International Special Award for elevating an onshore processing facility to the proactive level in maintenance execution—a first in Shell's history.

Additionally, I bring deep knowledge of Operational Readiness and Assurance (OR&A), including CSU (Commissioning and Start-Up) activities, as well as operational reliability improvement initiatives like ORIP and IAP (Integrated Activity Planning).

I lead by example, championing HSE (Health, Safety, and Environment) and leveraging global experience across six countries and three continents. My leadership style is driven by authenticity and a commitment to fostering diverse and inclusive teams.

I am an IT Manager with experience in the following industries: Pharma, Government, Banking and TelCo. I have a strong propensity for technological innovation, and its use inside companies to proactively contribute to processes improvement along the entire value chain.

Something about me from the professional point of view.
- Passionate of technology - My first pc, TI99/4A, when I was 11
- A strong advocate of adopting detailed work plans as enabler to get any goal
- Equipped with practical sense
- Being able to listen and valorize my team contribution

My history.
I graduated in Mathematics at the University of Rome, Tor Vergata. After a collaboration with the university, I worked in Mediamed Interactive, developing digital training solutions for the sales force of Pharma industry. After this experience, I joined Accenture and Avanade where I was involved in big projects/programs for the largest national and multinational companies.

After the consulting experience, I moved to Biomedica Foscama Group where, for more than five years, I was the head of IT department. Then, I moved to Alfasigma to lead IT activities for the Manufacturing area. Currently I’m in charge of IT development for the Manufacturing area covering all Alfasigma plants, with a particular focus on Industry 4.0. I’m also the CTO for the Pescara plant.

Ambitious and accomplished engineering leader with over 25 years of experience in driving operational excellence and strategic initiatives within matrix and multicultural environments in the pharmaceutical industry. Proven expertise in leading global teams, optimizing asset, and delivering projects.

Certified in Advanced Asset Management, with a focus on Continuous Improvement, Engineering, Performance, Digitalization and Compliance. Adept at fostering innovation, enhancing productivity, and creating significant business value through strategic execution and delivery.

The Pop in Your Job: In my role at GSK, I deliver innovative smart engineering solutions across various sites, focusing on enhancing asset uptime, equipment reliability, maintenance effectiveness, manufacturing capacity, and overall productivity. What drives me is the opportunity to collaborate with diverse teams, making their daily tasks easier and more efficient. I am passionate about the impact of new technologies on improving people's work experiences. The connection with sites worldwide allows me to embrace different cultures and address unique needs. Working for GSK, a company dedicated to bettering and improving human health, aligns with my values and commitment to contributing to a healthier world.

With over 15 years of specialized experience in pharmaceutical and biotech engineering, Oliver Kaerst is a distinguished leader in the field. As Head of Global Healthcare Operations (GHO) Engineering, he oversees engineering and capital expenditure initiatives across 20 manufacturing sites worldwide, driving excellence in pharmaceutical manufacturing and packaging.

Oliver has a proven track record in leading global pharma engineering and packaging reliability programs, including the successful integration of IoT and Industry 4.0 technologies. He also contributes as a key advisor on the Pharma Maintenance USA advisory board, where he offers expert guidance and highlights emerging trends in global maintenance practices.

His extensive background in strategic project management, regulatory compliance, and operational improvement underscores his leadership and deep expertise in optimizing complex global operations.

Sandoz is a global leader in off-patent medicines, based on our strong scientific heritage. Our purpose is to pioneer access for patients. We focus on driving access to make a difference for patients, working always with patients in mind.

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.

Our mission is to improve people's health and quality of life by offering caregivers and healthcare professionals therapeutic solutions according to the highest standards of quality and safety, in the name of innovation. Alfasigma is one of the leading Italian pharmaceutical companies, operating in over 100 countries worldwide with approximately 4,000 employees dedicated to research, development, production, and distribution. With more than 70 years of history, the Company has a longstanding track record in developing innovative therapeutic indications to meet the new needs of patients while renewing and consolidating its existing products. Alfasigma has a strong focus in gastroenterology and worldwide has products also in vascular, metabolic areas and in nutraceuticals and medical foods. As part of its strategy to expand its specialty care portfolio, Alfasigma strengthened its international presence with targeted acquisitions in US and Europe in 2023. Alfasigma’s historical headquarters are located in Bologna, with another office in Milan. It has production sites in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI), and abroad in Tortosa, Spain and in Shreveport (Louisiana) in the United States. Its R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo.

GSK is a global biopharma company with a mission to unite science, technology, and talent to get ahead of disease together. Our goal is to positively impact the health of 2.5 billion people by the end of the decade, fostering a thriving environment for our team. As a focused biopharma company, we specialize in preventing and treating diseases through specialty medicines, vaccines, and general medicines. Our research concentrates on the science of the immune system and advanced technologies, with significant investments in respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Our Ahead Together strategy emphasizes early intervention to prevent and change the course of diseases, supporting people and healthcare systems. We aim to discover new, better medicines and vaccines while also preventing illnesses and mitigating their long-term impacts. Our robust portfolio and pipeline continue to grow, with key milestones achieved across our core therapeutic areas in 2023. Strategic partnerships, such as those with the University of Oxford on neurodegenerative diseases, Kings College London on cancer treatment, and 23andMe on genetics and genomics, are vital to our discovery efforts. Our culture at GSK is driven by a commitment to being ambitious for patients, accountable for impact, and doing the right thing, ensuring that GSK remains an exciting and inspiring place to work. Our Code outlines the commitments we uphold to achieve our goals and bring our culture to life, making GSK a place where people can thrive.

Our passion for science and technology is what drives our around 63,000 employees across 65 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live. We are here for people at every step, helping create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services, and digital platform make research simpler, more exact, and help to deliver breakthroughs more quickly. We provide progressive treatment solutions that help improve access to health thanks to the accuracy of our tests and the reliability of our medicine. As a company, we are at the forefront of digital living. Our science sits inside technologies that change the way we access, store, process, and display information. Our innovative technology drives human progress and opens new possibilities to transform life on Earth as we know it. Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we’ve been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.